Hamilton Robotics

Zymo said it has already created optimized methods for microbiomics and RNA isolation for use on Hamilton's platforms.

Thermo Fisher will now offer a range of Hamilton products, a number of which automate existing Applied Biosystems forensics workflows.

Grand Interactive said this week that it has developed PCR Essentials, a mobile application to enable researchers and technicians equipped with iOS and Android-based mobile devices to obtain real-time performance data from Life Technologies' ProFlex PCR S

NEW YORK (GenomeWeb News) – New England Biolabs and Hamilton Robotics today announced a collaboration to develop automated solutions for NEB's line of reagents for next-generations sequencing sample preparation.

NEW YORK (GenomeWeb News) – Illumina today said that it has launched a partnership program aimed at developing automation methods for its TruSeq and Nextera Sample Preparation kits.

Integrated DNA Technologies has launched an enhanced version of the open access PrimerQuest online tool for PCR primer and probe design.

Swift Biosciences has launched Accel-NGS DNA Library Kit, a PCR-free library prep kit that requires 5 nanograms of input DNA.

Covaris last week introduced a single-tube FFPE DNA extraction kit for high-yield, large molecular weight DNA extraction from formalin-fixed, paraffin-embedded tissue samples.

NEW YORK (GenomeWeb News) – Hamilton Robotics today said that it has partnered with Affymetrix on the development of a target preparation system for Affy's CytoScan cytogenetics assay.

Exiqon this week launched MiRcury RNA Isolation Kit-Biofluids for extraction of small RNAs from serum, plasma, urine, and other biofluids.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.